Drug recall · October 11, 2023
Epinephrine-Lidocaine HCl recall
Why: Subpotent: Failing Test Results for Epinephrine
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-01 Not for resale. Office use only. Lot: 23APR018 Date Compounded: 24APR2023 Expires on: 17APR2024. In case of adverse event contact: www.fda.gov/medwatch or (800)-FDA-1088 Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852 (844) 446-6979
- Lots / codes
23APR018
- Quantity
- 364 bags (1 mL filled in 2 mL glass amber vials; 20 vials shipped in a bag)
- Company
- Imprimis NJOF, LLC, Ledgewood, NJ
- Distribution
- Nationwide
- Initiated
- October 3, 2023 · Voluntary: Firm initiated
- Classified
- October 5, 2023
- Reported
- October 11, 2023
- Ended
- March 21, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.